Plant essential oils and mastitis disease: Their potential inhibitory effects on pro-inflammatory cytokine production in response to bacteria related inflammation

Natural Product Communications

Volumn 7, Issue 5, 2012, Pages 675-682

  Taga, Ibrahim ^a   Lan, Christopher Q ^a   Altosaar, Illimar ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Anti inflammatory; Biotherapy; Cytokines; Essential oils; Folk medicine; Inflammation; Mastitis; Natural antibacterial; Tea tree oil

Indexed keywords

CINEOLE; CYTOKINE; ESSENTIAL OIL; PARA CYMENE; TEA TREE OIL; TERPINEN 4 OL; TERPINENE; VOLATILE ORGANIC COMPOUND;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; BACILLUS; BACTERIAL INFECTION; CANDIDA ALBICANS; CYTOKINE PRODUCTION; DRUG ACTIVITY; DRUG MECHANISM; DRUG POTENCY; DRUG SCREENING; ESCHERICHIA COLI; INFLAMMATION; MASTITIS; MELALEUCA; MELALEUCA ALTERNIFOLIA; NONHUMAN; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS DYSGALACTIAE; STREPTOCOCCUS UBERIS;

MAMMALIA; MELALEUCA ALTERNIFOLIA;

EID: 84861501214     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1200700534     Document Type: Review

References (109)

1. Sarma SN, Kim YJ, Ryu JC. (2008) Differential gene expression profiling in human promyelocytic leukemia cells treated with benzene and ethylbenzene. Molecular & Cellular Toxicology, 4, 267-277.
2. Degenhardt DC, Refi-Hind S, Stratmann JW, Lincoln DE. (2010) Systemin and jasmonic acid regulate constitutive and herbivore-induced systemic volatile emissions in tomato. Solanum lycopersicum. Phytochemistry, 71, 2024-2037.
3. Degenhardt J, Kollner TG, Gershenzon J. (2009) Monoterpene and sesquiterpene synthases and the origin of terpene skeletal diversity in plants. Phytochemistry, 70, 1621-1637.
4. Padovan A, Keszei A, Kollner TG, Degenhardt J, Foley WJ. (2010) The molecular basis of host plant selection in Melaleuca quinquenervia by a successful biological control agent. Phytochemistry, 71, 1237-1244.
5. Bood KG, Zabetakis I. (2002) The biosynthesis of strawberry flavor (II): biosynthetic and molecular biology studies. Journal of Food Science, 67, 2-8. (Pubitemid 34190769)
6. Schwab W, Davidovich-Rikanati R, Lewinsohn E. (2008) Harnessing plant biomass for biofuels and biomaterials biosynthesis of plant-derived flavor compounds. The Plant Journal, 54, 712-732.
7. Cao XL, Boissard C, Juan AJ, Hewitt CN, Gallagher M. (1997) Biogenic emissions of volatile organic compounds from gorse (Ulex europaeus): Diurnal emission fluxes at Kelling Heath, England. Journal of Geophysical Research-Atmospheres, 102, 18903-18915.
8. Hassiotis CN, Lazari DM. (2010) Decomposition process in the Mediterranean region. Chemical compounds and essential oil degradation from Myrtus communis. International Biodeterioration & Biodegradation, 64, 356-362.
9. Clarke JO, Mullin GE. (2008) A review of complementary and alternative approaches to immunomodulation. Nutrition and Clinical Practice, 23, 49-63.
10. Grose MJ. (2011) Landscape and children's health: Old natures and new challenges for the preventorium. Health & Place, 17, 94-102.
11. Boissard C, Cao XL, Juan CY, Hewitt CN, Gallagher M. (2001) Seasonal variations in VOC emission rates from gorse (Ulex europaeus). Atmospheric Environment, 35, 917-927. (Pubitemid 32170382)
12. Bao H, Kondo A, Kaga A, Tada M, Sakaguti K, Inoue Y, Shimoda Y, Narumi D, Machimura T. (2008) Biogenic volatile organic compound emission potential of forests and paddy fields in the Kinki region of Japan. Environmental Research, 106, 156-169. (Pubitemid 351162980)
13. Tava A, Cecotti R, Grecchi M, Falchero L, Coppa M, Lombardi G. (2011) Volatile constituents of Festuca nigrescens, Phleum alpinum and Poa alpina from N.W. Italian alpine pastures. Natural Product Communications, 6, 101-105.
14. Rogerio AP, Aandrade EL, Leite DFP, Figueiredo CP, Calixto JB. (2009) Preventive and therapeutic anti-inflammatory properties of the sesquiterpene a-humulene in experimental airways allergic inflammation. British Journal of Pharmacology, 158, 1074-1087.
15. Carson CF, Hammer KA, Riley TV. (2006) Melaleuca alternifolia (tea tree) oil: a review of antimicrobial and other medicinal properties. Clinical Microbiology, 19, 50-62. (Pubitemid 43158450)
16. Hammer KA, Carson CF, Dunstan JA, Hale J, Lehmann H, Robinson CJ, Prescott, SL, Riley TV. (2008) Antimicrobial and anti-inflammatory activity of five Taxandria fragrans oils in vitro. Microbiology and Immunology, 52, 522-530.
17. Hammer KA, Carson CF, Riley TV. (1998) In-vitro activity of essential oils, in particular Melaleuca alternifolia (tea tree) oil and tea tree oil products, against Candida spp. Journal of Antimicrobial Chemotherapy, 42, 591-595. (Pubitemid 28510617)
18. Carson CF, Mee BJ, Riley TV. (2002) Mechanism of action of Melaleuca alternifolia (tea tree) oil on Staphylococcus aureus determined by time-kill, lysis, leakage, and salt tolerance assays and electron microscopy. Antimicrobial Agents and Chemotherapy, 46, 1914-1920. (Pubitemid 34535215)
19. Cox SD, Mann CM, Markham JL, Bell HC, Gustafson JE, Warmington JR, Wyllie SG. (2000) The mode of antimicrobial action of the essential oil of Melaleuca alternifolia (tea tree). Journal of Applied Microbiology, 88, 170-175. (Pubitemid 30140195)
20. Imai H, Osawa K, Yasuda H, Hamashima H, Arai T, Sasatsu M. (2001) Inhibition by the essential oils of peppermint and spearmint of the growth of pathogenic bacteria. Microbios, 106, 31-39. (Pubitemid 33689350)
21. Wilkinson JM, Cavanagh HM. (2005) Antibacterial activity of essential oils from Australian native plants. Phytotherapy Research, 19, 643-646. (Pubitemid 41375249)
22. Wanner J, Schmidt E, Bail S, Jirovetz L, Buchbauer G, Gochev V, Girova T, Atanasova T, Stoyanova A. (2010) Chemical composition, olfactory evaluation and antimicrobial activity of selected essential oils and absolutes from Morocco. Natural Product Communications, 5, 1349-1354.
23. Juhás S, Cikos S, Czikková S, Veselá J, Il'ková G, Hájek T, Domaracká K, Domaracký M, Bujnáková D, Rehák P, Koppel J. (2008) Effects of borneol and thymoquinone on TNBS-induced colitis in mice. Folia Biologica, 54, 1-7. (Pubitemid 351210798)
24. Joshi SC, Verma AR, Mathela CS. (2010) Antioxidant and antibacterial activities of the leaf essential oils of Himalayan Lauraceae spp. Food Chemistry and Toxicology, 48, 38-40.
25. Kalemba D, Kunicka A. (2003) Antibacterial and antifungal properties of essential oils. Current Medicinal Chemistry, 10, 813-829. (Pubitemid 36443237)
26. Lo Cantore P, Shanmugaiah V, Iacobellis NS. (2009) Antibacterial activity of essential oil components and their potential use in seed disinfection. Journal of Agricultural and Food Chemistry, 50, 9454-9461.
27. Held S, Schieberle P, Somoza V. (2007) Characterization of R-terpineol as an anti-inflammatory component of orange juice by in vitro studies using oral buccal cells. Journal of Agricultural and Food Chemistry, 55, 8040-8046.
28. Hart PH, Brand C, Carson CF, Riley TV, Prager RH, Finlay-Jones JJ. (2000) Terpinen-4-ol, the main component of the essential oil of Melaleuca alternifolia (tea tree), suppresses inflammatory mediator production by activated human monocytes. Inflammation Research, 49, 619-626.
29. Hammer KA, Carson CF, Riley TV. (2003) Antifungal activity of the components of Melaleuca alternifolia (tea tree) oil. Journal of Applied Microbiology, 95, 853-860. (Pubitemid 37186670)
30. Papadopoulos CJ, Carson CF, Hammer KA, Riley TV. (2006) Susceptibility of Pseudomonas to Melaleuca alternifolia (tea tree) oil and components. Journal Antimicrobial Chemotherapy, 58, 449-451. (Pubitemid 44294964)
31. Oliva B, Piccirilli E, Ceddia T, Pontieri E, Aureli P, Ferrini AM. (2003) Antimycotic activity of Melaleuca alternifolia essential oil and its major components. Letter of Applied Microbiology, 37, 185-187. (Pubitemid 36930210)
32. Kim HJ, Chen F, Wu C, Wang X, Chung HY, Jin Z. (2004) Evaluation of antioxidant activity of Australian tea tree (Melaleuca alternifolia) oil and its components. Journal of Agricultural and Food Chemistry, 52, 2849-2854.
33. Wichmann G, Mühlenberg J, Fischäder G, Kulla C, Rehwagen M, Herbarth O, Lehmann I. (2005) An experimental model for the determination of immunomodulating effects by volatile compounds. Toxicology in Vitro, 19, 685-693. (Pubitemid 40719543)
34. Yoon WJ, Moon JY, Song G, Lee YK, Han MS, Lee JS, Ihm BS, Lee WJ, Lee NH, Hyun CG. (2010) Artemisia fukudo essential oil attenuates LPS-induced inflammation by suppressing NF-kappaB and MAPK activation in RAW 264.7 macrophages. Food Chemistry Toxicology, 48, 1222-1229.
35. Hirota R, Roger NN, Nakamura H, Song HS, Sawamura M, Suganuma N. (2010) Anti-inflammatory effects of limonene from yuzu (Citrus junos tanaka) essential oil on eosinophils. Journal of Food Science, 75, 87-92.
36. Chao LK, Hua KF, Hsu HY, Cheng SS, Liu JY, Chang ST. (2005) Study on the anti-inflammatory activity of essential oil from leaves of Cinnamomum osmophloeum. Journal of Agricultural and Food Chemistry, 53, 7274-7278. (Pubitemid 41375346)
37. Caldefie-Chézet F, Guerry M, Chalchat JC, Fusillier C, Vasson MP, Guillot J. (2004) Anti-inflammatory effects of Melaleuca alternifolia essential oil on human polymorphonuclear neutrophils and monocytes. Free Radical Research, 38, 805-811. (Pubitemid 39089039)
38. Penido C, Conte FP, Chagas MSS, Rodrigues CAB, Pereira JFG, Henriques MGMO. (2006) Antiinflammatory effects of natural tetranortriterpenoids isolated from Carapa guianensis Aublet on zymosan-induced arthritis in mice. Inflammation Research, 55, 457-464. (Pubitemid 44826734)
39. Opal SM, DePalo VA. (2000) Anti-inflammatory cytokines. Chest, 117, 1162-1172. (Pubitemid 30228378)
40. Juhás Š, Bukovská A, Čikoš Š, Czikková S, Fabian D, Koppel J. (2009) Anti-inflammatory effects of Rosmarinus officinalis essential oil in mice. Acta Veterinaria Brno, 78, 121-127.
41. FAO, Milk dairy products. (2009) Investment Centre Division. Viale delle Terme di Caracalla, 00153 Rome, Italy.
42. Tan X, Jiang YW, Huang YJ, Hu SH. (2009) Persistence of gentamicin residues in milk after the intramammary treatment of lactating cows for mastitis. Journal of Zhejiang University Science B, 10, 280-284.
43. Medzhitov R, Janeway CA. (1997) Innate immunity: the virtues of a nonclonal system of recognition. Cell, 91, 295-298. (Pubitemid 27467959)
44. Medzhitov R. (2008) Origin and physiological roles of inflammation. Nature, 454, 428-435.
45. Feghali CA, Wright TM. (1997) Cytokines in acute and chronic inflammation. Frontiers in Bioscience (online), 2, D12-26.
46. Zecconi A, Binda E, Dapra V, Hemling T, Piccinini R. (2005) Field study on protocols for evaluation of teat skin conditions. Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health, 52, 219-225. (Pubitemid 41595302)
47. Pretolani M. (1998) Cytokines dans l'inflammation allergique. Revue Française d'Allergologie et d'Immunologie Clinique, 38, 942-946.
48. Loram LC, Fuller A, Fick LG, Cartmell T, Poole S, Mitchell D. (2007) Cytokine profiles during carrageenan-induced inflammatory hyperalgesia in rat muscle and hind paw. The Journal of Pain, 8, 127-136. (Pubitemid 46188623)
49. Bachoual R, Boczkowski J. (2005) Role of cytokines in bronchopulmonary inflammation. EMC-Pneumologie, 2, 74-85. (Pubitemid 43237376)
50. Oltenacu PA, Broom DM. (2010) The impact of genetic selection for increased milk yield on the welfare of dairy cows. Animal Welfare, 19, 39-49.
51. Islas-Rodrìguez AE, Marcellini L, Orioni B, Barra D, Stella L, Mangoni ML. (2009) Esculentin 1-21: a linear antimicrobial peptide from frog skin with inhibitory effect on bovine mastitis-causing bacteria. Journal of Peptide Science, 15, 607-614.
52. Mitterhuemer S, Petzl W, Krebs S, Mehne D, Klanner A, Wolf E, Zerbe H, Blum H. (2010) Escherichia coli infection induces distinct local and systemic transcriptome responses in the mammary gland. BMC Genomics, 11, 1-16.
53. Pillar CM, Goby L, Draghi D, Grover P, Thornsberry C. (2009) Evaluating the in vitro susceptibility of bovine mastitis pathogens to a combination of kanamycin and cefalexin: recommendations for a disk diffusion test. Journal of Dairy Science, 92, 6217-6227.
54. Tomasinsig L, De Conti G, Skerlavaj B, Piccinini R, Mazzilli M, D'Este F, Tossi A, Zanetti M. (2010) Broad-spectrum activity against bacterial mastitis pathogens and activation of mammary epithelial cells support a protective role of neutrophil cathelicidins in bovine mastitis. Infection and Immunity, 78, 1781-1788.
55. Massart-Leën AM, Burvenich C, Massart DL. (1994) Triacylglycerol fatty acid composition of milk from periparturient cows during acute Escherichia coli mastitis. Journal of Dairy Research, 61, 191-199.
56. Halasa T, Nielen M, De Roos AP, Van Hoorne R, de Jong G, Lam TJ, van Werven, T, Hogeveen H. (2009) Production loss due to new subclinical mastitis in Dutch dairy cows estimated with a test-day model. Journal of Dairy Research, 92, 599-606.
57. Goodridge L, Hill AR, Lencki RW. (2004) A review of international standards and the scientific literature on farm milk bulk-tank sampling protocols. Journal of Dairy Research, 87, 3099-3104. (Pubitemid 39225033)
58. Elmoslemany AM, Keefe GP, Dohoo IR, Wichtel JJ, Stryhn H, Dingwell RT. (2010) The association between bulk tank milk analysis for raw milk quality and on-farm management practices. Preventive Veterinary Medicine, 95, 32-40.
59. Sakemi Y, Tamura Y, Hagiwara K. (2011) Interleukin-6 in quarter milk as a further prediction marker for bovine subclinical mastitis. Journal of Dairy Research, 78, 118-121.
60. Akerstedt M, Forsbäck L, Larsen T, Svennersten-Sjaunja K. (2011) Natural variation in biomarkers indicating mastitis in healthy cows. Journal of Dairy Research, 78, 88-96.
61. Riekerink RO, Barkema H. (2006) Mastitis: The Canadian perspective. WCDS Advances in Dairy Technology, 18, 275-283.
62. Lunin N. (1881) Ueber die bedeutung der anorganishen salze fur die ernahrung des thieres. Verzeichniss der benutzten Literatur, 5, 31-39.
63. Rodriguez E, Towers GHN, Mftcheu JC. (1976) Biological activities of sesquiterpene lactones. Phytochemistry, 15, 1573-1580.
64. Wagner KH, Elmadfa I. (2003) Biological relevance of terpenoids. Overview focusing on mono-, di- and tetraterpenes. Annals of Nutrition and Metabolism, 47, 95-106.
65. Grassmann J, Schneider D, Weiser D, Elstner EF. (2001) Antioxidative effects of lemon oil and its components on copper induced oxidation of low density lipoprotein. Arzneimittelforschung, 51, 799-805. (Pubitemid 33001100)
66. Grassmann J. (2005) Terpenoids as plant antioxidants. Vitamins & Hormones, Plant Hormones. Litwack G. (Ed.), 72, 505-535.
67. Chao LK, Hua KF, Hsu HY, Cheng SS, Lin F, Chen CJ, Chen ST, Chang ST. (2008) Cinnamaldehyde inhibits pro-inflammatory cytokines secretion from monocytes/macrophages through suppression of intracellular signaling. Food and Chemical Toxicology, 46, 220-231. (Pubitemid 350235768)
68. Juergens UR, Stöber M, Vetter H. (1998) The anti-inflammatory activity of L-menthol compared to mint oil in human monocytes in vitro: a novel perspective for its therapeutic use in inflammatory diseases. European Journal of Medical Research, 3, 539-545.
69. Juergens UR, Engelen T, Racké K, Stöber M, Gillissen A, Vetter H. (2004) Inhibitory activity of 1,8-cineol (eucalyptol) on cytokine production in cultured human lymphocytes and monocytes. Pulmonary Pharmacology and Therapeutics, 17, 281-287. (Pubitemid 39345409)
70. Zhou JY, Tang FD, Mao GG, Bian RL. (2004) Effect of alpha-pinene on nuclear translocation of NF-kappa B in THP-1 cells. Acta Pharmacologica Sinica, 25, 480-484.
71. Serafino A, Sinibaldi VP, Andreola F, Zonfrillo M, Mercuri L, Federici M, Rasi G, Garaci E, Pierimarchi P. (2008) Stimulatory effect of Eucalyptus essential oil on innate cell-mediated immune response. BMC Immunology, 9, 1-16.
72. Sforcin JM, Amaral JT, Fernandes JA, Sousa JPB, Bastos JK. (2009) Lemongrass effects on IL-1β and IL-6 production by macrophages. Natural Product Research, 12, 1151-1159.
73. Camp RDR. (2004) The Wizard of Oz, or the intriguing tale of the tea tree. Journal of Investigative Dermatology, 123, xviii-xix.
74. Khalil Z, Pearce AL, Satkunanathan N, Storer E, Finlay-Jones JJ, Hart PH. (2004) Regulation of wheal and flare by tea tree oil: complementary human and rodent studies. Journal of Investigative Dermatology, 123, 683-690. (Pubitemid 39281609)
75. Brand C, Ferrante A, Prager RH, Riley TV, Carson CF, Finlay-Jones JJ, Hart PH. (2001) The water-soluble components of the essential oil of Melaleuca alternifolia (tea tree) suppress the production of superoxide by human monocytes, but not neutrophils, activated in vitro. Inflammation Research, 50, 213-219. (Pubitemid 32382247)
76. Caldefie-Chézet F, Fusillier C, Jarde T, Laroye H, Damez M, Vasson MP, Guillot J. (2006) Potential anti-inflammatory effects of Melaleuca alternifolia essential oil on human peripheral blood leukocytes. Phytotherapy Research, 20, 364-370.
77. Haddad PS, Azar GA, S Groom S, Boivin M. (2005) Natural health products, modulation of immune function and prevention of chronic diseases. Evidence-based Complementary and Alternative Medicine, 4, 513-520. (Pubitemid 41752488)
78. Golab M, Skwarlo-Sonta K. (2007) Mechanisms involved in the anti-inflammatory action of inhaled tea tree oil in mice. Experimental Biology and Medicine, 232, 420-426. (Pubitemid 46334059)
79. International standard ISO 4730. (2004) (Oil of Melaleuca, Terpinen-4-ol type).
80. Paduch R, Kandefer-Szerszeń M, Trytek M, Fiedurek J. (2007) Terpenes: substances useful in human healthcare. Archivum Immunologiae et Therapiae, 55, 315-327.
81. Haigou R, Miyazawa M. (2012) Metabolism of (+)-terpinen-4-ol by cytochrome P450 enzymes in human liver microsomes. Journal of Oleo Science (Japan Oil Chemists' Society), 61, 35-43.
82. Brand C, Townley SL, Finlay-Jones JJ, Hart PH. (2002) Tea tree oil reduces histamine-induced oedema in murine ears. Inflammation Research, 51, 283-289. (Pubitemid 34628030)
83. Calcabrini A, Stringaro A, Toccacieli L, Meschini S, Marra M, Colone M, Salvatore G, Mondello F, Arancia G, Molinari A. (2004) Terpinen-4-ol, the main component of Melaleuca alternifolia (tea tree) oil inhibits the in vitro growth of human melanoma cells. Journal of Investigative Dermatology, 122, 349-360. (Pubitemid 38281055)
84. Greay SJ, Ireland DJ, Kissick HT, Levy A, Beilharz MW, Riley TV, Carson CF. (2010) Induction of necrosis and cell cycle arrest in murine cancer cell lines by Melaleuca alternifolia (tea tree) oil and terpinen-4-ol. Cancer Chemotherapy and Pharmacology, 65, 877-888.
85. Wu CS, Chen YJ, Chen JJW, Shieh JJ, Huang CH, Lin PS, Chang GC, Chang JT, Lin CC. (2012) Terpinen-4-ol induces apoptosis in human non small cell lung cancer in vitro and in vivo. Evidence-based Complementary and Alternative Medicine, Article ID 818261, 13 pages.
86. Budhiraja SS, Cullum ME, Sioutis SS, Evangelista L, Habanova ST. (1999) Biological activity of Melaleuca alternifola (tea tree) oil component, terpinen-4-ol, in human myelocytic cell line HL-60. Journal of Manipulative and Physiological Therapeutics, 22, 447-453. (Pubitemid 29474871)
87. Hammer KA, Carson CF, Riley TV. (2012) Effects of Melaleuca alternifolia (tea tree) essential oil and the major monoterpene component terpinen-4-ol on the development of single- and multi-step antibiotic resistance and antimicrobial susceptibility. Antimicrobial Agents Chemotherapy, 56, 909-915.
88. Thomsen PS, Jensen TM, Hammer KA, Carson CF, Mølgaard P, Riley TV. (2011) Survey of the antimicrobial activity of commercially available Australian tea tree (Melaleuca alternifolia) essential oil products in vitro. Alternative and Complementary Medicine, 17, 835-841.
89. Carson CF, Hammer KA, Riley TV. (1996) In vitro activity of the essential oil of Melaleuca alternifolia against Streptococcus spp. (Letter). Journal of Antimicrobial Chemotherapy, 37, 1177-1178. (Pubitemid 26258064)
90. Carson CF, Riley TV, Cookson BD. (1998) Efficacy and safety of tea tree oil as a topical antimicrobial agent. Journal of Hospital Infection, 40, 175-178. (Pubitemid 28502301)
91. EU 2004 Opinion on tea tree oil. European Commission Health & Consumer Protection DG, Directorate C Public Health and Risk Assessment, C7 - Risk assessment. Adopted by the SCCP during the 2nd plenary meeting of 7 December 2004; SCCP/0843/04.
92. Carson CF, Riley TV. (1995) Antimicrobial activity of the major components of the essential oil of Melaleuca alternifolia. Journal of Applied Bacteriology, 78, 264-269.
93. Rajamannan AHJ. (1993) Product and process for treating bovine mastitis and bovine metritis. Minneapolis, Agro-K Corporation Inc. US patent #5260341.
94. Hassler MA, Hassler LM. (1998) Bovine mastitis treatment. US Patent US 5,846,543.
95. Reusser KL, Reusser GG, Schmidt MJ. (2001) Compositions comprising Oleum Melaleuca. Safe'N Sound Solutions, Inc., Beaverton, OR (US). US patent # 6168794 B1.
96. Manzoni B. (2002) Phyto-derivative disinfectant solution for veterinary use in the endo-mammary anti-mastitis treatment of milk-producing animals. 24030 Berbenno, (Bergamo) (IT); Ing. A. Giambrocono & C. S.r.1., 20129 Milano (IT). EU patent # EP 1 230927 A1.
97. Omini CF. (2004) Topical pharmaceutical compositions containing natural active constituents suitable for the prevention and treatment of mucosal inflammation processes. B.S.D. Bio Science Development di Omini & Zuccari SNC. 20060 Bussero (Milano) (IT). EU patent # EP 1 444 984 B1.
98. Paolo A. (2008) Veterinarian compositions containing terpinen-4-ol for the treatment and prevention of mastitis. Gitto, Serena et al.; Barzanò & Zanardo Roma S.p.A.Via Piemonte, 2600187 Roma (IT). EU patent # EP 2 138 171 A1.
99. Jing XQ, Zhao YQ, Shang CC, Yao YL, Tian TT, Li J, Chen DK. (2012) Dynamics of cytokines associated with IL-17 producing cells in serum and milk in mastitis of experimental challenging with Staphylococcus aureus and Escherichia coli in dairy goats. Journal of Animal and Veterinary Advances, 11, 475-479.
100. Avancini C, Wiest JM, Dall'Agnol R, Haas JS, von Poser GL. (2008) Antimicrobial activity of plants used in the prevention and control of bovine mastitis in Southern Brazil. Latin American Journal of Pharmacy, 27, 894-899.
101. Chiang HM, Chiu HH, Lai YM, Chen CY, Chiang HL. (2010) Carbonyl species characteristics during the evaporation of essential oils. Atmospheric Environment, 44, 2240-2247.
102. Carson CF, Riley TV. (1993) Antimicrobial activity of the essential oil of Melaleuca alternifolia. Letters in Applied Microbiology, 16, 49-55. (Pubitemid 23054498)
103. Southwell IA, Hayes AJ, Markham J, Leach DN. (1993) The search for optimally bioactive Australian tea tree oil. Conference: International Symposium on Medicinal and Aromatic Plants, 344, 256-265.
104. Boman HG. (2003) Antibacterial peptides: basic facts and emerging concepts. Journal of Internal Medicine, 254, 197-215.
105. Hoffmann JA. (2008) The antimicrobial host defense of Drosophila: a paradigm for innate immunity. Conference: Joint Conference of the 33rd FEBS Congress/11th IUBMB; FEBS Journal, 275, 45.
106. Loit E, Hincke MT, Altosaar I. (2010) Synthetic antimicrobial peptide L8 (MHLHKTSRVTLYLL) has membrane permeabilisation and bacterial aggregation activity. International Journal of Antimicrobial Agents, 35, 410-411.
107. Cheng XY, Liu GZ, Ye GY, Wang HJ, Shen XJ, Wu KC, Xie JH, Altosaar I. (2009) Screening and cloning of antimicrobial DNA sequences using a vital staining method. Gene, 430, 132-139.
108. Wall ML, Wheeler HL, Smith J, Figeys D, Altosaar I. (2010) Mass spectrometric analysis reveals remnants of host-pathogen molecular interactions at the starch granule surface in wheat endosperm. Phytopathology, 100, 848-854.
109. Shen XJ, Ye GY, Cheng XY, Yu CY, Altosaar I. (2010) Characterization of an abaecin-like antimicrobial peptide identified from a Pteromalus puparum cDNA clone. Journal of Invertebrate Pathology, 105, 24-29.